Antony developed Synvichor based on the results of the ELIJA clinical trials across Australia. Previously, he was involved in the successful development and commercialisation of SeptiCyte™ technology for Immunexpress in Seattle USA.

Antony is a medical doctor who spent 5 years training in orthopaedic surgery in Australia and is a PhD candidate in molecular genomics.

Michael was the co-founder of Global Orthopaedic Technology and presided over the commercialisation and expansion of the company for 15 years.

Michael is an experienced member of several boards and brings a wealth of experience in commercialising orthopaedic technology to the board at OrthoDx.

David is an IT professional with extensive experience in international enterprise organisations across multiple industries. His early career saw him working with British Aerospace, Pacific Aerospace, and the US government on projects involving plane manufacture, micro satellites, and military aircraft. Transitioning to IT, David has worked in the UK, USA, Canada, and Australia, contributing to companies such as AMP, Toyota, Toyota Finance, McKesson, Medibank, and many others. ​
​
David helped establish McKesson’s Australian IT department, where he created Asia-Pacific’s largest remote workforce, significantly impacting rural emergency healthcare. This program’s success led to Medibank’s acquisition of McKesson Asia-Pacific.

Raelene has more than 20 years of experience in providing taxation, accounting and business advisory services to private companies, subsidiaries of multinationals, partnerships and trusts.

Raelene’s strength is in identifying and advising on financial obstacles, to enhance performance and opportunities for business growth.

Victor is a patent attorney specialising in patent applications in all areas of biotechnology.

With a PhD in biochemistry and molecular biology, postdoctoral experience at the Walter and Eliza Hall Institute of Medical Research and the Queensland Institute of Medical Research, Victor has been instrumental in OrthoDx’s international patent applications for synovial biomarkers.

Richard is an orthopaedic surgeon based in Bundaberg, Queensland, specialising in adult joint replacement and paediatric orthopaedic surgery.

He honed his expertise through prestigious Canadian university fellowships where he developed a particular interest in bone and joint infections. Richard also holds an MBA from the Australian Institute of Business and has a keen interest in medical and corporate governance.

Kevin is a senior orthopaedic surgeon based principally in Brisbane, Australia, and recognised internationally for his expertise in the management of complex trauma and orthopaedic implant-related infections.

As an Associate Professor at the University of Queensland, Kevin is dedicated to delivering quality patient care, while also active in ground breaking research of the highest calibre.

Andrew is a senior orthopaedic surgeon based in Adelaide, South Australia. He is renowned for his expertise in musculoskeletal health, particularly complex joint replacement and major orthopaedic trauma.

Andrew is also a senior academic, researcher and clinical educator at both Flinders University and the University of Adelaide. He has extensive experience in cutting-edge orthogenomics, technology-supported surgery and complex revision arthroplasty.

Jeffrey is a renowned figure in the field of critical care medicine and infectious diseases. He has actively participated in global health initiatives and has worked tirelessly to improve patient outcomes.

Jeffrey is an Emeritus Professor at the University of Queensland, and long-time researcher in sepsis.

Jonathan is an orthopaedic and trauma surgeon based in Sydney, Australia, best known for his proficiency in treating complex fractures and injuries.

Jonathan is also a Senior clinical lecturer at the University of Sydney and Macquarie University. His work has contributed to the development of innovative surgical techniques and the advancement of patient care.